This is a snippet of the transcript, sign up to read more.
For a long time, firms in the B2B SaaS platform space have relied on their ecosystem play to retain customers. But this may not be as strong a pull as it used to be, especially in the future. At one point, integrations between platforms were rare, so being part of one ecosystem had an edge. That doesn't hold true anymore. There's also the issue of shelfware with any ecosystem or platform. When a customer purchases licensing, they often buy bundled products, resulting in many unused products within that bundle. Customers are waking up to this reality and may prefer smaller platforms that cater to their use case, even if they have to interact with a few disparate platforms.
This is a snippet of the transcript, sign up to read more.
Of course, this doesn't apply to really large enterprises where that may not be feasible. But we need to remember that ServiceNow doesn't deal with only one set of customers. Their customer pool is diverse. Some customers might start thinking that if they have a huge shelfware issue, they don't need to be part of an ecosystem. With many adapters and connectors available these days, it's not a strong pull. This opens the gate for many other firms to compete for the same set of customers.
This is a snippet of the transcript, sign up to read more.
ServiceNow has done this very well. Their AI agents are something they're pursuing aggressively. Their performance has been evaluated for quite a few years, especially for specific use cases, and they perform very well compared to other third-party LLMs. The fact that they have integrated it within their platform, making it a natural part of the customer journey rather than a separate offering, is quite rare and difficult to achieve. Many other firms have tried to create an AI agent playground for end users to develop their own AI agents, but that didn't work well. ServiceNow has the edge because they made the entire experience seamless. However, due to the sheer size of ServiceNow, there can be delays in R&D developments reaching end customers. They have a lot in store, but not all of it is being released quickly enough. If they manage to address this, they'll be in a very good position.
This is a snippet of the transcript, sign up to read more.
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2025 IP 1 Ltd. All rights reserved.
Subscribe to access hundreds of interviews and primary research